Panacea Biotec Launches - CABAPAN, A cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)

March 28, 2016

Panacea Biotec Launches - CABAPAN, A cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)